South San Francisco Newswire

South San Francisco Newswire

Comprehensive Real-Time News Feed for South San Francisco, CA.

Results 1 - 7 of 7 for "u:freshnews.com" in South San Francisco, CA

  1. Compugen to Present at 28th Annual Piper Jaffray Healthcare Conference in New YorkRead the original story w/Photo

    Nov 21, 2016 | Freshnews

    Compugen Ltd. Location: Israel GEOTAG: Israel Tags: Bloomberg:[email protected] , Bloomberg:[email protected] , Bloomberg:[email protected] , Compugen Ltd. , ISIN:IL0010852080 , Israel , NASDAQ-NMS:CGEN , NYSEArca:CGEN , PR Newswire , RICS:CGEN , RICS:CGEN.F , RICS:CGEN.O , RICS:CGEN.P , TelAviv:CGEN , United States of America

    Comment?

  2. LakePharmaa s 4th Protein Engineering Symposium Draws Record AttendanceRead the original story w/Photo

    Oct 13, 2016 | Freshnews

    The 4 annual LakePharma Protein Engineering Symposium was held at the South San Francisco Conference Center on Oct. 7th. Over 300 local scientists attended the day-long event, featuring presentations from Stanford, local biotech companies including Atreca, GigaGen, and TeneoBio, and large pharma companies including Janssen, Pfizer and Grifols.

    Comment?

  3. True North Therapeutics Receives FDA Orphan Drug Designation for TNT009 for the Treatment...Read the original story w/Photo

    Oct 13, 2016 | Freshnews

    FDA has granted Orphan Drug Designation for True North's lead product candidate, TNT009 for the treatment of autoimmune hemolytic anemia, including Cold Agglutinin Disease True North Therapeutics Receives FDA Orphan Drug Designation for TNT009 for the Treatment of Autoimmune Hemolytic Anemia, including Cold Agglutinin Disease True North Therapeutics, a clinical stage biotechnology company developing novel product candidates that selectively inhibit the Complement system to treat certain rare diseases, today announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation for the Company's lead product candidate, TNT009 for the treatment of autoimmune hemolytic anemia, including Cold Agglutinin Disease , a form of autoimmune hemolytic anemia for which there are limited treatment options available for patients.

    Comment?

  4. Compugen to Present at the Annual Meeting of the Society for Immunotherapy of...Read the original story w/Photo

    Oct 7, 2016 | Freshnews

    Compugen Ltd. , a leading predictive drug discovery company, today announced that John Hunter, Ph.D., Site Head and Vice President, Antibody R&D, Compugen USA, Inc., will present data on the Company's CGEN-15029 novel immune checkpoint program at the 31st Annual Meeting of the Society for Immunotherapy of Cancer [http://www.sitcancer.org/2016 ] to be held November 9-13 at the Gaylord National Hotel & Convention Center in National Harbor, Maryland. The presentation titled "Computational identification, functional characterization and antibody blockade of a new immune checkpoint in the TIGIT family of interacting molecules" is scheduled for Friday, November 11 at 11:45 am ET.

    Comment?

  5. Netswitch Launches SecurliXF for Advanced Cybersecurity Detection and ResponseRead the original story w/Photo

    Oct 4, 2016 | Freshnews

    The Gartner Group recently named SecurliA as one of twelve representative Managed Detection and Response Services in the world and positioned BlackStratus, a leading provider of cloud-based security and compliance technology in their 2016 Magic Quadrant for SIEM for a 3rd year. Netswitch has now partnered with BlackStratus to offer SecurliXFA , the integration of their award-winning MDR platform with CYBERShark, BlackStratus's new SaaS offering to address the increased sophistication of existential threats to the network for the middle market.

    Comment?

  6. Biotech Stocks on Investorsa Radar a " Portola Pharma, bluebird bio, Auris Medical, and...Read the original story w/Photo

    Sep 22, 2016 | Freshnews

    Today, Stock-Callers.com has initiated research reports on these biotech stocks: Portola Pharmaceuticals Inc. , bluebird bio Inc. , Auris Medical Holding A.G. , and Cerulean Pharma Inc. . Yesterday, the markets were on a bullish course with all indices in the green.

    Comment?

  7. Compugen Discloses Development of Enhanced LINKS Platform Utilized for the Discovery of Myeloid...Read the original story w/Photo

    Aug 30, 2016 | Freshnews

    Compugen Ltd. , a leading predictive drug discovery company, today disclosed that its LINKS computational platform, initially designed for the characterization and differentiation of existing novel drug target candidates, has been enhanced to include the in silico discovery of new immuno-oncology drug targets, with a specific focus on the discovery of myeloid targets within the tumor microenvironment . LINKS now allows the Company to broaden its existing repertoire of immune checkpoint targets, which already includes a few myeloid targets, predicted by algorithms and methodologies previously developed by the Company.

    Comment?

South San Francisco Job Listings
View or post South San Francisco job listings on Topix.
South San Francisco Real Estate
News, listings, and foreclosures in South San Francisco from Topix.
South San Francisco Mortgages
Find mortgage rates in South San Francisco on Topix.